Part 1: Pharmaceutical Serialisation – The Challenges We, As a CDMO, Are Facing

Counterfeit drugs account for approximately $75 billion in global annual losses. To address this, anti-counterfeiting measures, such as serialisation, are making packaging as important as the drug it is tasked with protecting. Serialisation is a means to track and trace products, and legislation is already enforced in countries like Brazil, South Korea and China. It is due to come into effect in the US in 2017 and in all European countries by Feb 2019 for all prescription drugs.

Serialisation systems must be configurable to meet the needs of the country in which the end product is to be distributed. In order for contract manufacturers, like Aesica, to be able to continue to serve their pharmaceutical customers, they must implement a serialisation capability that is able to deliver the required complexity and flexibly.

In this first webinar, Christian Gross, Packaging Technology Manager at Aesica, will discuss the industry's preparedness for serialisation legislation and Aesica's serialisation solution, from concept to delivery.

Christian Groß is the Manager Packaging Technology and Project Manager Serialisation at Aesica Pharmaceuticals. As part of his role as Project Manager, he has driven the implementation of serialisation and aggregation at Aesica’s facility in Germany.

Christian has over 20 years’ experience in the pharmaceutical industry. He started his career as a Packaging Technologist at Schwarz Pharma before joining Aesica in 2009 as Head of Packaging Technology and Artwork Services. Christian holds a degree in Digital and Print media.